Stay updated with breaking news from Stephens stakes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DermTech (NASDAQ:DMTK – Get Free Report)‘s stock had its “equal weight” rating reaffirmed by equities researchers at Stephens in a research note issued on Friday, Benzinga reports. They presently have a $1.50 price objective on the stock. Stephens’ price target points to a potential upside of 132.92% from the company’s previous close. Separately, BTIG Research […] ....
Stephens reaffirmed their overweight rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock. CareDx Stock Up 3.0 % Shares of CDNA stock opened at $8.31 on Wednesday. The firm has a market cap of $430.29 […] ....
Stephens reaffirmed their equal weight rating on shares of OncoCyte (NASDAQ:OCX – Free Report) in a research report released on Wednesday, Benzinga reports. They currently have a $4.00 price target on the stock. Several other research analysts have also commented on OCX. Benchmark reaffirmed a speculative buy rating and set a $5.00 price objective on […] ....
Stephens restated their overweight rating on shares of Old Second Bancorp (NASDAQ:OSBC – Free Report) in a research note issued to investors on Friday morning, Benzinga reports. The firm currently has a $17.00 price target on the financial services provider’s stock. Separately, Raymond James upgraded Old Second Bancorp from an outperform rating to a strong-buy […] ....